Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

February 16, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Anesthesia, SpinalArthroplasty, Replacement, Knee
Interventions
DRUG

Mepivacaine

Patients will be administered a standard dose of mepivacaine 1.5% (4.5ml, 67.5mg) for total knee arthroplasty prior to surgery

DRUG

Bupivacaine

Patients will be administered a standard dose of 0.75% hyperbaric bupivacaine (1.4ml, 10.5mg) for total knee arthroplasty prior to surgery

Trial Locations (1)

29615

Prisma Health Patewood Hospital, Greenville

All Listed Sponsors
lead

Prisma Health-Upstate

OTHER

NCT06291727 - Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA | Biotech Hunter | Biotech Hunter